Verify your email address to receive email notifications.

Verification sent. Please check your inbox to verify your address.

Unable to send verification. Please try again later.

article / 03 Oct 2017

Preparing you with tools to manage the Codeine changes



As of the 1st of February 2018, codeine-containing medications will be prescription-only, the Therapeutic Goods Administration (TGA) has declared (1).

The decision has been driven by the serious risks associated with taking over-the-counter medicines with codeine as an active ingredient. Increased tolerance and strong withdrawal symptoms can lead to codeine addiction, posing serious long-term health risks (2).

Dr Michael Gannon from the Australian Medical Association has stated that deaths and illness from codeine use have increased in Australia and is encouraging patients with chronic pain to avoid self-treating and seek appropriate advice from their Doctors on medicines and non-medicine treatments (3).

Healthshare have partnered with Indivior to provide you with information on Opioid Dependence and its management

Free Support Guides or managing patients with Opioid Dependence
It is likely you will have some patients expressing their concern or distress about the change in regulations and its impact on their treatment.

Opioid dependence in your patients – Information for Healthcare professionals

What is opioid dependence? - Information for Patients

Suboxone® – A treatment option for Opioid Dependence

Opioid dependence and SUBOXONE – Information for Healthcare Professionals

Treating opioid dependence with SUBOXONE Sublingual Film – Information for Healthcare Professional

Suboxone PI

  1. Codeine Information Hub – Therapeutic Goods Administration accessed Oct 2017
  2. Causes of Death Australia, 2016 – Australian Bureau of Statistics Issue 3303.0 accessed Oct 2017
  3. AMA Backs TGA on Codeine – Australian Medical Association, Media Release, 10 August 2017

See All Press